Is Ventas Stock Outperforming the Nasdaq?

NodeGuardian

2026-03-23 20:43:20

Abstract generation in progress

Ventas, Inc. (VTR) has shown strong performance, with its stock gaining 12.2% over the past three months, significantly outperforming the Nasdaq Composite’s 3.2% losses during the same period. The healthcare REIT, valued at $41.7 billion, also surpassed Wall Street expectations with its Q4 revenues and FFO. Analysts maintain a “Strong Buy” rating for VTR, projecting a potential upside of 3.9%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.